136 related articles for article (PubMed ID: 37768837)
1. Subcutaneous Tranexamic Acid at the End of Life in a Patient With Hereditary Hemorrhagic Telangiectasia.
Arndt G; Wai R; Stiel H
J Palliat Med; 2024 Jun; 27(6):827-829. PubMed ID: 37768837
[TBL] [Abstract][Full Text] [Related]
2. Intranasal tranexamic acid for the treatment of hereditary hemorrhagic telangiectasia: a case report and review of treatment options.
Flanagan BA; Collins C; Parra S
Cutis; 2012 Feb; 89(2):69-72. PubMed ID: 22474728
[TBL] [Abstract][Full Text] [Related]
3. Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study.
Geisthoff UW; Seyfert UT; Kübler M; Bieg B; Plinkert PK; König J
Thromb Res; 2014 Sep; 134(3):565-71. PubMed ID: 25005464
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.
Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Ramirez JR; Morales-Angulo C; Zarrabeitia R; Perez-Molino A; Bernabéu C; Botella LM
Thromb Haemost; 2007 Feb; 97(2):254-62. PubMed ID: 17264955
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of tranexamic acid in a patient with hereditary hemorrhagic telangiectasia and massive epistaxis].
Pérez del Molino A; Zarrabeitia R; Fernández A; Botella LM
Med Clin (Barc); 2004 Jun; 123(3):118-9. PubMed ID: 15225479
[No Abstract] [Full Text] [Related]
7. Definite hereditary hemorrhagic telangiectasia in a 60-year-old black Kenyan woman: a case report.
Kiyeng JC; Siika A; Koech C; Bloomfield GS
J Med Case Rep; 2016 May; 10(1):126. PubMed ID: 27225226
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease.
Gaillard S; Dupuis-Girod S; Boutitie F; Rivière S; Morinière S; Hatron PY; Manfredi G; Kaminsky P; Capitaine AL; Roy P; Gueyffier F; Plauchu H;
J Thromb Haemost; 2014 Sep; 12(9):1494-502. PubMed ID: 25040799
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid and bevacizumab in hereditary hemorrhagic telangiectasia patients presenting with epistaxis.
Lacout A; Marcy PY; El Hajjam M; Lacombe P
Cutis; 2013 Apr; 91(4):173-4. PubMed ID: 23763075
[No Abstract] [Full Text] [Related]
10. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
Sabbà C; Gallitelli M; Palasciano G
N Engl J Med; 2001 Sep; 345(12):926. PubMed ID: 11565536
[No Abstract] [Full Text] [Related]
12. Tranexamic acid in hereditary hemorrhagic telangiectasia.
Lozano M
N Engl J Med; 2002 Feb; 346(6):457. PubMed ID: 11832543
[No Abstract] [Full Text] [Related]
13. Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia.
Klepfish A; Berrebi A; Schattner A
Arch Intern Med; 2001 Mar; 161(5):767. PubMed ID: 11231712
[No Abstract] [Full Text] [Related]
14. Tranexamic acid-bevacizumab synergy in HHT patients presenting pulmonary arteriovenous malformations.
Lacout A; Marcy PY; El Hajjam M; Lacombe P
Med Hypotheses; 2012 Nov; 79(5):605-6. PubMed ID: 22959314
[TBL] [Abstract][Full Text] [Related]
15. Medical Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Meta-analysis.
Hsu YP; Hsu CW; Bai CH; Cheng SW; Chen C
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):22-35. PubMed ID: 30200816
[TBL] [Abstract][Full Text] [Related]
16. Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care.
Al-Samkari H
Blood; 2021 Feb; 137(7):888-895. PubMed ID: 33171488
[TBL] [Abstract][Full Text] [Related]
17. Tranexamic acid may be a useful pharmacotherapy for endoscopically resistant small bowel angiodysplasia.
Fujimori S
World J Gastroenterol; 2023 Feb; 29(7):1131-1138. PubMed ID: 36926669
[TBL] [Abstract][Full Text] [Related]
18. Treatments of Epistaxis in Hereditary Hemorrhagic Telangiectasia: Systematic Review and Network Meta-Analysis.
Chitsuthipakorn W; Hoang MP; Kanjanawasee D; Seresirikachorn K; Snidvongs K
Curr Allergy Asthma Rep; 2023 Dec; 23(12):689-701. PubMed ID: 37995018
[TBL] [Abstract][Full Text] [Related]
19. Hereditary haemorrhagic telangiectasia with protein S deficiency in a family: a case report.
Wechalekar A; Parapia L
Eur J Haematol; 2000 Jan; 64(1):59-60. PubMed ID: 10680707
[No Abstract] [Full Text] [Related]
20. [Pharmacological treatment of hereditary haemorrhagic telangiectasia].
Molinos-Castro S; Pesqueira-Fontán PM; Díaz-Peromingo JA
Rev Med Chil; 2009 May; 137(5):695-700. PubMed ID: 19701561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
